Stereotactic radiotherapy in the treatment of paraneoplastic vasculitis in oligometastatic renal cell carcinoma

3Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Approximately 20% of renal cell carcinoma (RCC) is diagnosed because of paraneoplastic manifestations. RCC has been associated with a large variety of paraneoplastic syndromes (PNS), but it is rarely associated with PNS vasculitis. We present a case of a previously healthy male who presented with systemic vasculitis; bitemporal headaches, diplopia, polyarthritis, palpable purpura, tongue lesion, peri-orbital edema, scleritis, chondritis and constitutional symptoms. He was subsequently found to have oligometastatic RCC. Both his primary lesion and site of oligometastasis were treated with stereotactic radiotherapy (SBRT) and resulted in the resolution of his vasculitis, as well as sustained oncologic response. This is the first case to demonstrate that effective sustained treatment for PNS vasculitis due to oligometastatic RCC is possible with SBRT.

Cite

CITATION STYLE

APA

Burgess, L., Keenan, M., Zhou, A. L., Lypka, K., Saraqini, D. H., Yao, J., … Macrae, R. (2021). Stereotactic radiotherapy in the treatment of paraneoplastic vasculitis in oligometastatic renal cell carcinoma. Current Oncology, 28(3), 1744–1750. https://doi.org/10.3390/curroncol28030162

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free